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Abstract
Introduction:  Global  sugar  consumption  has  increased  in  the  past  50  years;  its  abusive  intake  is
responsible for  peripheral  insulin  resistance,  which  causes  the  metabolic  syndrome  --  obesity,
diabetes mellitus,  hypertension,  and  coronary  heart  disease.
Objective:  To  evaluate  the  effect  of  a  fractionated  diet  without  glucose  as  treatment  for
labyrinthine  disorders  associated  with  glucose--insulin  index.
Methods:  The  study  design  was  a  prospective  randomized  controlled  trial.  Fifty-one  patients
were divided  into  two  groups:  the  diet  group  (DG),  which  comprised  subjects  treated  with  a
fractionated  diet  with  glucose  restriction,  and  the  control  group  (CG),  in  which  individuals  were
not counseled  regarding  diet.  Patients  underwent  computerized  dynamic  posturography  (CDP)
and visual  analog  scale  (VAS)  on  the  first  and  30th  days  of  the  study.
Results:  There  was  improvement  in  the  assessed  posturographic  conditions  and  VAS  self-
assessment  in  the  DG  group  after  30  days  when  compared  to  the  control  group.
Conclusion:  The  fractionated  diet  with  glucose  restriction  was  effective  for  the  treatment  of
vestibular  dysfunction  associated  with  glucose  metabolism  disorders.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/). Please cite this article as: Bittar RSM, Santos MA, Mezzalira R. Glucose metabolism disorders and vestibular manifestations: evaluation
hrough computerized dynamic posturography. Braz J Otorhinolaryngol. 2016;82:372--6.
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PALAVRAS-CHAVE
Tontura;
Transtornos  do
metabolismo  de
glicose;
Dieta  com  restric¸ão
de carboidratos
Distúrbios  do  metabolismo  da  glicose  e  manifestac¸ões  vestibulares:  avaliac¸ão  pela
posturografia  dinâmica  computadorizada
Resumo
Introduc¸ão:  O  consumo  mundial  de  ac¸úcar  triplicou  nos  últimos  50  anos  e  a  sua  ingesta  abu-
siva é  responsável  pela  resistência  periférica  à  insulina  que  origina  a  síndrome  metabólica  --
obesidade,  diabetes  mellitus,  hipertensão  arterial  e  doenc¸as  coronarianas.
Objetivo:  Avaliar  de  forma  objetiva  o  efeito  da  dieta  fracionada  e  sem  glicose  como  forma  de
tratamento  dos  distúrbios  labirínticos  associados  às  alterac¸ões  da  curva  glicoinsulinêmica.
Método:  Trata-se  de  um  ensaio  clínico  controlado  randomizado  prospectivo.  Estudo  realizado
com 51  pacientes  divididos  em  dois  grupos:  Grupo  Dieta  composto  por  indivíduos  tratados  com
dieta fracionada  com  restric¸ão  de  glicose  e  Grupo  Controle  no  qual  os  indivíduos  não  foram  ori-
entados em  relac¸ão  à  dieta.  Os  pacientes  realizaram  Posturografia  Dinâmica  Computadorizada
e Escala  Análogo  Visual  no  primeiro  e  trigésimo  dias  do  estudo.
Resultados:  Foi  observada  melhora  nas  condic¸ões  posturográficas  avaliadas  e  melhora  clínica
do grupo  dieta  na  análise  da  escala  análogo  visual  quando  comparados  grupo  dieta  e  grupo
controle.
Conclusão: A  dieta  fracionada  e  restritiva  de  glicose  mostrou-se  eficaz  no  tratamento  das
disfunc¸ões vestibulares  associadas  aos  distúrbios  do  metabolismo  da  glicose.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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Global  sugar  consumption  has  tripled  in  the  past  50  years,
and  its  abusive  intake  is  responsible  for  peripheral  insulin
resistance,  which  leads  to  the  metabolic  syndrome  --  obe-
sity,  diabetes  mellitus,  hypertension,  and  coronary  heart
disease.1,2 An  estimated  40%  of  individuals  with  weight  con-
sidered  normal  develop  some  form  of  metabolic  syndrome,
as  a  result  of  glucose  consumption.3 According  to  the  same
authors,  in  the  United  States  the  situation  has  become  a
matter  of  national  security,  as  young  individuals  are  becom-
ing  increasingly  obese  and  unfit  for  military  service.
The  significance  of  glucose  metabolism  disorders  (GMD)
can  be  observed  in  otoneurology  when  their  high  preva-
lence  is  observed  in  patients  with  labyrinth  disorders.4 It  is
estimated  that  between  30%  and  90%  of  patients  with  dizzi-
ness  have  altered  levels  of  blood  glucose  and  insulin.5--8 In
recent  years,  several  authors  have  investigated  GMD  as  a
cause  of  inner  ear  dysfunctions.4,5,7,9,10 Moreover,  vestibular
dysfunction  has  been  described  as  a  new  complication  of
diabetes  and  acts  as  a  potentiating  risk  factor  for  falls  in
these  patients.11
Based  on  the  above  observations,  it  was  decided  to  assess
the  postural  performance  of  patients  with  dizziness  and  a
clinical  history  of  GMD  after  a  fractionated  diet  with  glucose
restriction,  in  order  to  test  the  hypothesis  that  this  diet  is
effective  in  the  treatment  of  vestibular  dysfunctions  associ-
ated  with  this  condition.  The  aims  of  this  study  included:
1.  Assess  the  posturography  conditions  on  a  moving  plat-
form  (conditions  4,  5,  6)  and  the  composite  score
in  patients  with  body  balance  disorders  and  glucose
metabolism  alterations  before  and  after  a  fractionated
diet  with  glucose  restriction  for  30  days.
M
A
l.  Assess  the  impact  of  the  fractionated  diet  with  carbohy-
drate  restriction  on  the  quality  of  life  of  patients  with
body  balance  disorders  and  glucose  metabolism  alter-
ations  using  the  visual  analog  scale  (VAS).
ethods
his  was  a  prospective,  randomized,  controlled  clinical  trial,
reviously  approved  by  the  Research  Ethics  Committee  of
he  institution  (No.  482/05)  and  registered  in  the  Clinical
rial  Protocol  Registration  System  (NTC  02,226,536).  All  par-
icipants  in  the  study  signed  the  informed  consent.
The  study  subjects  were  adults  older  than  18  years.
hey  underwent  all  the  necessary  examinations  to  attain  a
nal  diagnosis  of  vestibular  disorder:  audiometry,  videonys-
agmography,  electrophysiological  tests,  and  imaging  tests
hen  needed.  Among  these,  individuals  with  dizziness
elated  to  food  (fasting  and/or  after  sugar  intake)  and  who
ad  an  altered  three-hour  glucose  tolerance  test,  namely:
lood  glucose  ≤  55  mg/dL;  and/or  blood  glucose  between
45  and  199  mg/dL  in  the  second  hour  of  the  test  and/or;
um  of  insulin  levels  of  the  second  and  third  hours  >60  U/mL
ere  selected  for  study.12--15
Patients  with  complaints  non-attributable  to  the  ves-
ibular  system,  orthopedic  or  neurological  disorders  that
ight  interfere  with  the  computerized  dynamic  posturogra-
hy  (CDP),  and  diabetic  patients  according  to  the  American
iabetes  Association  (2010  and  2011)  were  not  included  in
he  study.13,14
Patients  diagnosed  with  vestibular  disorders  such  as
eniere’s  disease  (anamnesis  supported  by  the  American
cademy  criteria)  were  also  not  included  in  the  study.
Non-vestibular  dizziness  symptoms  are  those  without
abyrinthine  characteristics  (such  as  those  related  to
3 Bittar  RSM  et  al.
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Table  1  C4  values  in  DG  and  CG  on  day  one  and  day  30.
C4  Day  one  Day  30  p-Value
Group Mean  ±  SD  Mean  ±  SD
Diet  69.24  ±  15.21 77.09  ±  9.73  0.0128
Control  62.30  ±  14.50  61.94  ±  15.22  0.9991
p-Value  0.0420  0.0002
C4, condition 4 of posturography; DG, diet group; CG, control
group.
Table  2  C5  values  in  the  DG  and  CG  on  day  one  and  day
30.
C5  Day  one  Day  30  p-Value
Group Mean  ±  SD  Mean  ±  SD
Diet  42.75  ±  23.68 59.87  ±  16.99 0.0015
Control  44.91  ±  19.06  43.15  ±  17.29  0.9804
p-Value  0.9616  0.0028
C5, condition 5 of posturography; DG, diet group; CG, control
group.
Table  3  C6  values  in  the  DG  and  CG  on  day  one  and  day
30.
C6  Day  one  Day  30  p-Value
Group Mean  ±  SD  Mean  ±  SD
Diet  41.17  ±  18.03  55.23  ±  15.95  0.0024
Control  45.65  ±  18.03  46.93  ±  14.66  0.9874
p-Value  0.6370  0.1390
C6, condition 6 of posturography; DG, diet group; CG, control
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posturographic  conditions  before  and  after  the  diet  period,
there  was  significant  improvement  in  the  DG  in  relation  to
the  CG  in  all  of  them,  as  shown  in  Tables  1--4.
Table  4  CS  values  in  the  DG  and  CG  on  day  one  and  day
30.
CS  Day  one  Day  30  p-Value
Group Mean  ±  SD  Mean  ±  SD74  
ovement  or  vertigo),  such  as:  syncope,  visual  darkening,
taxia,  light  headedness,  head  pressure.
There  were  no  patient  exclusions.
The  sample  consisted  of  51  patients,  42  females  and  nine
ales,  divided  into  two  groups:
.  Diet  Group  (DG):  26  individuals  who  received  a  fraction-
ated  diet  every  three  hours  with  sugar  restriction.
.  Control  Group  (CG):  25  individuals  who  kept  their  regular
diet.  There  were  no  dietary  restrictions.
Patients  were  always  randomized  by  the  same  examiner,
ccording  to  the  numerical  order  of  arrival  at  the  service.
oth  groups  were  instructed  to  ingest  a  corn  starch  tablet
placebo)  twice  a  day,  which  was  delivered  by  the  investi-
ator  at  the  start  of  the  intervention.
All  study  subjects  were  asked  about  the  clinical  char-
cteristics  of  their  dizziness.  To  quantify  self-perception  of
ody  balance,  the  subjects  answered  using  a  VAS,  in  which
ero  meant  no  dizziness  and  ten  meant  the  worst  possi-
le  dizziness.  Postural  assessment  was  conducted  by  CDP
hrough  a  sensory  organization  test  (SOT),  Equitest  System®
ersion  4.0  (NeuroCom  Internacional  --  United  States).
Both  the  VAS  and  the  SOT  were  carried  out  at  two
oments  of  the  study:  the  first  day  (D1)  and  after  30  days,
hen  the  dietary  intervention  ended  (D30).
After  30  days,  patients  in  both  groups  delivered  the
ackage  with  the  placebo  tablets  so  that  the  examiner  could
bserve  whether  the  tablets  had  been  ingested.  Adherence
o  the  proposed  dietary  treatment  was  investigated  through
he  question:  ‘‘Did  you  follow  the  daily  diet  as  indicated?’’
tatistical  analysis
he  primary  variables  considered  were  the  posturographic
onditions  C4,  C5,  and  C6  (conditions  4,  5,  6,  which  are
latform-oscillating  conditions)  and  composite  score  (CS),
o  assess  the  impact  of  vestibular  responses  and  their  effect
n  the  final  postural  maintenance.4,16--18 VAS  responses  were
lso  considered,  characterizing  the  self-perception  of  treat-
ent  impact  on  early  symptoms.
For  the  statistical  analysis  the  following  tests  were  used:
 Chi-squared  tests.19
 Student’s  t-test.19
 Fisher’s  exact  test.20
 Cochran’s  test.19
 Analysis  of  variance  (ANOVA).19
 Tukey’s  test.19
esults
ample  characterization
he  DG  consisted  of  26  subjects,  mean  age  of  45.8  ±  11.3
ears.  The  CG  consisted  of  25  patients,  mean  age  of
2  ±  13.7  years.  Forty-two  patients  (82.4%)  were  females
nd  nine  males  (17.6%).  The  values  found  showed  normal
istribution.  When  compared  by  the  Student’s  t-test  and
isher’s  exact  test,  the  groups  were  homogeneous  regarding
ender  distribution  (p  =  0.948)  and  age  (p  =  0.086).group.
Regarding  the  clinical  characterization  of  dizziness  and
he  results  of  the  glucose  tolerance  test,  the  chi-squared
nd  Cochran  tests  were  used.  The  most  common  types  of
izziness  were  floating  (70.5%)  and  the  feeling  of  imbal-
nce  (60%).  The  most  frequent  laboratory  diagnosis  was
yperinsulinemia,  present  in  76.47%  of  cases.  Hypoglycemia
ccurred  in  21.56%  of  the  sample.
The  ANOVA  test  was  applied  to  assess  variables  C4,
5,  C6,  CS,  VAS,  and  Tukey’s  multiple  comparisons,  which
dentified  the  significant  differences.19 When  comparingDiet  64.28  ±  11.37  73.44  ±  8.80  0.0002
Control  64.55  ±  9.62  63.95  ±  10.61  0.9838
p-Value  0.9984  0.0002
CS, composite score; DG, diet group; CG, control group.
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Table  5  VAS  values  in  the  DG  and  CG  on  day  one  and  day
30.
VAS  Day  one  Day  30  p-Value
Group  Mean  ±  SD  Mean  ±  SD
Diet  7.78  ±  1.75  4.04  ±  3.73  0.0002
Control  7.38  ±  2.10  6.50  ±  3.15  0.5913
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Rp-Value  0.9347  0.0044
VAS, visual analog scale; DG, diet group; CG, control group.
A  significant  improvement  was  observed  in  VAS  in  the
DG  on  day  30  when  compared  to  the  first  day  of  the  study
(p  =  0.0002)  and  when  compared  to  the  CG  (p  =  0.0044).  The
results  are  shown  in  Table  5.
Discussion
The  majority  of  the  assessed  cases  (82.4%)  belonged  to  the
female  gender,  similarly  to  what  is  found  in  the  literature.
Hormonal  changes  in  women  between  the  fourth  and  fifth
decades  of  life  mark  the  onset  of  climateric  period,  whose
manifestations  may  include  water  retention  and  metabolic
and  anxiety  disorders.4,21--23 In  this  age  group,  GMD  acts  as
a  migraine  trigger  and  can  also  be  responsible  for  triggering
postural  disorders.21,24
Anamnesis  is  crucial  for  the  diagnosis  of  dizziness  of
metabolic  origin,  including  GMD.  The  characteristics  found
in  this  sample  do  not  differ  from  those  in  the  literature;
the  most  prevalent  symptom  was  floating-type  dizziness  in
70.5%  of  patients,  followed  by  imbalance  in  60%  of  cases.4
The  glucose  tolerance  test  is  considered  the  most  impor-
tant  diagnostic  tool  in  the  assessment  of  patients  with
dizziness  and  GDM.6,25,26 When  the  most  frequently  observed
alterations  are  evaluated,  the  present  results  are  not  dissim-
ilar  from  those  found  in  the  literature,  and  hyperinsulinemia
was  the  most  common  abnormality,  observed  in  76.47%  of
cases.10,21,27,28 Clinical  trials  have  shown  that  the  fraction-
ated  diet  with  glucose  restriction  plays  an  important  role  in
the  treatment  of  patients  with  GMD.1,29,30 Therefore,  it  was
decided  use  a  diet  that  was  fractionated  every  three  hours,
together  with  glucose  restriction.
The  literature  reports  the  importance  of  the  placebo
effect  in  clinical  studies  that  propose  the  validation  of  a
certain  treatment.31,32 Approximately  35%  of  cases  show
a  positive  placebo  response,  because  they  generate  bio-
logical  phenomena  that  mimic  pharmacological  effects.33,34
The  placebo  was  intentionally  administered  to  both  groups
so  that  patients  would  feel  treated  and  followed  by  the
researcher.  This  fact  allows  one  to  exclude  the  diet  as  a
potential  placebo,  and  instead  consider  that  the  diet  was
the  factor  responsible  for  the  improvement  of  the  patients
assessed  in  the  DG.  Interestingly,  even  when  explaining  it  to
the  research  subjects,  only  one  of  them  questioned  the  use
of  a  pill  containing  no  therapeutic  effect.
At  baseline,  a  better  numeric  performance  in  C4  of  the
DG  when  compared  to  the  CG  (p  =  0.042)  was  observed.  At
the  end  of  the  study,  the  difference  found  between  the
groups  at  baseline  increased  to  a  highly  significant  value
(p  =  0.0002).  The  values  can  be  attributed  to  improvement
in  vestibular-visual  integration  after  the  diet.  There  was  a375
ignificant  improvement  in  the  DG  values  on  the  30th  day
hen  compared  to  the  first  measurement  of  C5  at  baseline
p  =  0.0015).  Still  in  C5,  the  better  vestibular  performance
f  the  DG  (p  =  0.0028)  when  compared  to  the  CG  (p  =  0.9804)
an  be  clearly  observed  on  the  30th  day  of  the  study.  As  for
6,  an  improvement  was  also  verified  regarding  the  values
bserved  on  the  30th  study  day  in  the  DG  (p  =  0.0024).
In  relation  to  the  CS,  the  DG  results  on  the  30th  day  of
he  study  were  higher  than  the  measures  obtained  on  the
rst  day  (p  =  0.0002),  as  they  were  also  higher  on  the  30th
ay  when  compared  to  the  CG  (p  =  0.0002).
The  results  demonstrate  better  postural  performance  in
he  DG  attributed  to  the  effect  of  diet  on  vestibular  function
f  the  subjects.  Thus,  this  study  reproduced  the  findings  of
ittar  et  al.  (2004),4 who  used  CDP  to  document  postural
ecovery  improvement  in  patients  with  GMD  submitted  to  a
ractionated  diet  with  glucose  restriction.
The  purpose  of  the  VAS  was  to  evaluate  the  self-
erception  of  symptom  discomfort  and  quantify  their
ubjective  evolution  as  a  result  of  the  followed  diet.31,35 A
ignificant  improvement  was  observed  regarding  the  level
f  discomfort  only  in  DG  patients  after  30  days  of  diet
p  =  0.0002),  as  well  as  compared  to  the  CG  (p  =  0.0044)  in
he  same  period.  Therefore,  it  can  be  inferred  that  the  diet
ad  a  positive  influence  on  the  self-perception  of  dizziness.
onclusion
obile  posturography,  CS,  and  VAS  showed  significantly  bet-
er  values  in  patients  submitted  to  30  days  of  fractionated
nd  glucose-restricted  diet  when  compared  to  the  Control
roup.
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